{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,6]],"date-time":"2026-05-06T06:41:27Z","timestamp":1778049687492,"version":"3.51.4"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172340"],"award-info":[{"award-number":["82172340"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82372317"],"award-info":[{"award-number":["82372317"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Medical Microbiology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/j.ijmm.2024.151619","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T17:03:14Z","timestamp":1711558994000},"page":"151619","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Characterization of BCP\/PreC\/C region quasispecies in treatment-naive patients with different phases of HBV infection using next-generation sequencing"],"prefix":"10.1016","volume":"315","author":[{"given":"Chenggong","family":"Zhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Minjie","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ya","family":"Fu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhen","family":"Xun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caorui","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Songhang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianbin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yongbin","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qishui","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Can","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"22","key":"10.1016\/j.ijmm.2024.151619_bib1","doi-asserted-by":"crossref","first-page":"11994","DOI":"10.1128\/JVI.00653-10","article-title":"Apoptosis of hepatitis B virus-infected hepatocytes prevents release of infectious virus [J]","volume":"84","author":"Arzberger","year":"2010","journal-title":"J. Virol."},{"issue":"9","key":"10.1016\/j.ijmm.2024.151619_bib2","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1136\/gutjnl-2012-302408","article-title":"Cumulative viral evolutionary changes in chronic hepatitis B virus infection precedes hepatitis B e antigen seroconversion [J]","volume":"62","author":"Cheng","year":"2013","journal-title":"Gut"},{"issue":"12","key":"10.1016\/j.ijmm.2024.151619_bib3","first-page":"938","article-title":"[The guidelines of prevention and treatment for chronic hepatitis B (2019 version)] [J]","volume":"27","year":"2019","journal-title":"Zhonghua Gan Zang Bing. Za Zhi"},{"issue":"2","key":"10.1016\/j.ijmm.2024.151619_bib4","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.jhep.2017.03.021","article-title":"EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection [J]","volume":"67","year":"2017","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.ijmm.2024.151619_bib5","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.jhep.2007.11.011","article-title":"Natural history of chronic hepatitis B: special emphasis on disease progression and prognostic factors [J]","volume":"48","author":"Fattovich","year":"2008","journal-title":"J. Hepatol."},{"issue":"8","key":"10.1016\/j.ijmm.2024.151619_bib6","doi-asserted-by":"crossref","DOI":"10.1128\/JCM.00119-19","article-title":"Characterization and Clinical Significance of Natural Variability in Hepatitis B Virus Reverse Transcriptase in Treatment-Naive Chinese Patients by Sanger Sequencing and Next-Generation Sequencing [J]","volume":"57","author":"Fu","year":"2019","journal-title":"J. Clin. Microbiol"},{"issue":"6","key":"10.1016\/j.ijmm.2024.151619_bib7","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1053\/jhep.2002.33638","article-title":"Long-term outcome after spontaneous HBeAg seroconversion in patients with chronic hepatitis B [J]","volume":"35","author":"Hsu","year":"2002","journal-title":"Hepatology"},{"issue":"8","key":"10.1016\/j.ijmm.2024.151619_bib8","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.cgh.2021.01.019","article-title":"Natural History and Hepatocellular Carcinoma Risk in Untreated Chronic Hepatitis B Patients With Indeterminate Phase [J]","volume":"20","author":"Huang","year":"2022","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"2","key":"10.1016\/j.ijmm.2024.151619_bib9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.3748\/wjg.v21.i2.541","article-title":"Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion [J]","volume":"21","author":"Kamijo","year":"2015","journal-title":"World J. Gastroenterol."},{"issue":"23","key":"10.1016\/j.ijmm.2024.151619_bib10","doi-asserted-by":"crossref","first-page":"4222","DOI":"10.3748\/wjg.v23.i23.4222","article-title":"Naturally occurring mutations in the reverse transcriptase region of hepatitis B virus polymerase from treatment-naive Korean patients infected with genotype C2 [J]","volume":"23","author":"Kim","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.ijmm.2024.151619_bib11","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1093\/molbev\/msw054","article-title":"MEGA7: Molecular Evolutionary Genetics Analysis Version 7.0 for Bigger Datasets [J]","volume":"33","author":"Kumar","year":"2016","journal-title":"Mol. Biol. Evol."},{"key":"10.1016\/j.ijmm.2024.151619_bib12","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.3389\/fmicb.2020.01653","article-title":"Differences in HBV Replication, APOBEC3 Family Expression, and Inflammatory Cytokine Levels Between Wild-Type HBV and Pre-core (G1896A) or Basal Core Promoter (A1762T\/G1764A) Mutants [J]","volume":"11","author":"Lau","year":"2020","journal-title":"Front Microbiol"},{"issue":"3","key":"10.1016\/j.ijmm.2024.151619_bib13","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000140","article-title":"Natural History of Untreated HBeAg-Positive Chronic HBV Infection With Persistently Elevated HBV DNA but Normal Alanine Aminotransferase [J]","volume":"11","author":"Lee","year":"2020","journal-title":"Clin. Transl. Gastroenterol."},{"issue":"4","key":"10.1016\/j.ijmm.2024.151619_bib14","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.3892\/mmr.2015.4072","article-title":"Biological characteristics of the A1762T\/G1764A mutant strain of hepatitis B virus in vivo [J]","volume":"12","author":"Leng","year":"2015","journal-title":"Mol. Med Rep."},{"issue":"3","key":"10.1016\/j.ijmm.2024.151619_bib15","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1053\/j.gastro.2007.06.011","article-title":"Viral quasi-species evolution during hepatitis Be antigen seroconversion [J]","volume":"133","author":"Lim","year":"2007","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.ijmm.2024.151619_bib16","doi-asserted-by":"crossref","first-page":"3755","DOI":"10.1002\/cam4.1610","article-title":"T cell receptor repertoire profiling predicts the prognosis of HBV-associated hepatocellular carcinoma [J]","volume":"7","author":"Lin","year":"2018","journal-title":"Cancer Med"},{"issue":"4","key":"10.1016\/j.ijmm.2024.151619_bib17","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/jcla.21857","article-title":"Accurate Detection of Hepatitis B Virus G1896A Mutant by Developed Taqman-ARMS Followed a Strict Control System [J]","volume":"30","author":"Lu","year":"2016","journal-title":"J. Clin. Lab Anal."},{"issue":"4","key":"10.1016\/j.ijmm.2024.151619_bib18","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.jhep.2011.11.012","article-title":"Quantitative dynamics of hepatitis B basal core promoter and precore mutants before and after HBeAg seroconversion [J]","volume":"56","author":"Nie","year":"2012","journal-title":"J. Hepatol."},{"issue":"1","key":"10.1016\/j.ijmm.2024.151619_bib19","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3390\/v14010082","article-title":"Global Disparities in Hepatitis B Elimination-A Focus on Africa [J]","volume":"14","author":"Sonderup","year":"2022","journal-title":"Viruses"},{"issue":"1","key":"10.1016\/j.ijmm.2024.151619_bib20","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jhep.2010.06.018","article-title":"Evolution of hepatitis B genotype C viral quasi-species during hepatitis B e antigen seroconversion [J]","volume":"54","author":"Wu","year":"2011","journal-title":"J. Hepatol."},{"issue":"2","key":"10.1016\/j.ijmm.2024.151619_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1038\/s41423-020-00601-8","article-title":"Taurocholic acid inhibits the response to interferon-alpha therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8(+) T and NK cell function [J]","volume":"18","author":"Xun","year":"2021","journal-title":"Cell Mol. Immunol."},{"key":"10.1016\/j.ijmm.2024.151619_bib22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cca.2019.12.020","article-title":"Albumin-bilirubin score is associated with response to pegylated interferon and nucleos(t)ide analogues in chronic hepatitis B patients [J]","volume":"502","author":"Xun","year":"2020","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.ijmm.2024.151619_bib23","article-title":"Proteomic characterization of the natural history of chronic HBV infection revealed by tandem mass tag-based quantitative proteomics approach [J]","volume":"15","author":"Xun","year":"2022","journal-title":"Mater. Today Bio"},{"issue":"4","key":"10.1016\/j.ijmm.2024.151619_bib24","article-title":"New point mutations in surface and core genes of hepatitis B virus associated with acute on chronic liver failure identified by complete genomic sequencing [J]","volume":"10","author":"Xu","year":"2015","journal-title":"PLoS One"},{"issue":"7","key":"10.1016\/j.ijmm.2024.151619_bib25","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1128\/JCM.00068-15","article-title":"Characterization of Full-Length Genomes of Hepatitis B Virus Quasispecies in Sera of Patients at Different Phases of Infection [J]","volume":"53","author":"Yang","year":"2015","journal-title":"J. Clin. Microbiol"},{"issue":"1","key":"10.1016\/j.ijmm.2024.151619_bib26","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s12072-015-9698-x","article-title":"Looking into the crystal ball: biomarkers for outcomes of HBV infection [J]","volume":"10","author":"Yang","year":"2016","journal-title":"Hepatol. Int"},{"issue":"2","key":"10.1016\/j.ijmm.2024.151619_bib27","doi-asserted-by":"crossref","first-page":"306","DOI":"10.3748\/wjg.v23.i2.306","article-title":"Phase IIb trial of in vivo electroporation mediated dual-plasmid hepatitis B virus DNA vaccine in chronic hepatitis B patients under lamivudine therapy [J]","volume":"23","author":"Yang","year":"2017","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.ijmm.2024.151619_bib28","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1111\/jvh.13511","article-title":"Distribution and clinical characteristics of patients with chronic hepatitis B virus infection in the grey zone [J]","volume":"28","author":"Yao","year":"2021","journal-title":"J. Viral Hepat."},{"issue":"20","key":"10.1016\/j.ijmm.2024.151619_bib29","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.3748\/wjg.v26.i20.2584","article-title":"Conservation and variability of hepatitis B core at different chronic hepatitis stages [J]","volume":"26","author":"Yll","year":"2020","journal-title":"World J. Gastroenterol."},{"issue":"6","key":"10.1016\/j.ijmm.2024.151619_bib30","first-page":"1425","article-title":"Guidelines for the Prevention and Treatment of Chronic Hepatitis B (version 2022) [J]","volume":"11","author":"You","year":"2023","journal-title":"J. Clin. Transl. Hepatol."},{"key":"10.1016\/j.ijmm.2024.151619_bib31","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.2147\/DDDT.S149623","article-title":"Halofuginone ameliorates inflammation in severe acute hepatitis B virus (HBV)-infected SD rats through AMPK activation [J]","volume":"11","author":"Zhan","year":"2017","journal-title":"Drug Des. Devel Ther."},{"issue":"9","key":"10.1016\/j.ijmm.2024.151619_bib32","first-page":"2033","article-title":"Should chronic hepatitis B in the indeterminate phase be treated? [J]","volume":"37","author":"Zhuang","year":"2021","journal-title":"J. Clin. Hepatol."}],"container-title":["International Journal of Medical Microbiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422124000237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1438422124000237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,15]],"date-time":"2024-06-15T19:18:17Z","timestamp":1718479097000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1438422124000237"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":32,"alternative-id":["S1438422124000237"],"URL":"https:\/\/doi.org\/10.1016\/j.ijmm.2024.151619","relation":{},"ISSN":["1438-4221"],"issn-type":[{"value":"1438-4221","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Characterization of BCP\/PreC\/C region quasispecies in treatment-naive patients with different phases of HBV infection using next-generation sequencing","name":"articletitle","label":"Article Title"},{"value":"International Journal of Medical Microbiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijmm.2024.151619","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"151619"}}